1 buyer · 4 sellers · 41% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 1 sold
Latest: sale, 2026-03-13
Planned sales (Form 144), 90 days
$14.4M
8 notices
Verisign insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, VERISIGN INC/CA insiders sold a net $22.2M of stock across 797 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
30 earlier Form 4 trades (code P or S) here by this insider (30 sales), the last on Apr 28, 2026.
The trade is 10.7% of the 30,548 shares held after it.
2 other insiders sold within 30 days.
482 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP - Technology & CSO McPherson Danny R sold about $989.5K of VRSN on Oct 26, 2026; 2 other insiders sold within 30 days and 482 funds added in the latest 13F quarter.
559 earlier Form 4 trades (code P or S) here by this insider (559 sales), the last on Oct 13, 2026.
The trade is 0.1% of the 374,727 shares held after it.
2 other insiders sold within 30 days.
482 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Exec. Chairman, Pres, & CEO BIDZOS D JAMES sold about $121.7K of VRSN under a 10b5-1 plan on Oct 20, 2026; 2 other insiders sold within 30 days and 482 funds added in the latest 13F quarter.
559 earlier Form 4 trades (code P or S) here by this insider (559 sales), the last on Oct 13, 2026.
The trade is 0.1% of the 374,527 shares held after it.
2 other insiders sold within 30 days.
482 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Exec. Chairman, Pres, & CEO BIDZOS D JAMES sold about $61.0K of VRSN under a 10b5-1 plan on Oct 20, 2026; 2 other insiders sold within 30 days and 482 funds added in the latest 13F quarter.
559 earlier Form 4 trades (code P or S) here by this insider (559 sales), the last on Oct 13, 2026.
The trade is 0.6% of the 372,227 shares held after it.
2 other insiders sold within 30 days.
482 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Exec. Chairman, Pres, & CEO BIDZOS D JAMES sold about $705.0K of VRSN under a 10b5-1 plan on Oct 20, 2026; 2 other insiders sold within 30 days and 482 funds added in the latest 13F quarter.
559 earlier Form 4 trades (code P or S) here by this insider (559 sales), the last on Oct 13, 2026.
The trade is 0.1% of the 371,827 shares held after it.
2 other insiders sold within 30 days.
482 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Exec. Chairman, Pres, & CEO BIDZOS D JAMES sold about $123.0K of VRSN under a 10b5-1 plan on Oct 20, 2026; 2 other insiders sold within 30 days and 482 funds added in the latest 13F quarter.
797 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
VRSN planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
DANNY MCPHERSON
Filed 2026-10-26
$989.5K
THOMAS C INDELICARTO
Filed 2026-10-08
$146.6K
THOMAS C INDELICARTO
Filed 2026-10-01
$142.2K
DEMETRIOS JAMES BIDZOS
Filed 2026-09-08
$12.5M
THOMAS C INDELICARTO
Filed 2026-09-08
$144.6K
VRSN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Eaton Vance Atlanta Capital Focused Growth Fund
$23.4M position · as of 2026-06-30
5.0%
VistaShares Target 15 Berkshire Select Income ETF
$42.1M position · as of 2026-07-31
4.3%
Calvert Equity Fund
$138.5M position · as of 2026-06-30
4.1%
AVE MARIA GROWTH FUND
$47.8M position · as of 2026-06-30
3.8%
AVE MARIA VALUE FUND
$20.3M position · as of 2026-06-30
3.8%
Pacer US Cash Cows Growth ETF
$4.4M position · as of 2026-07-31
3.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Bidzos
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$15.5M
$24.2M
$4.5M
+13%
+158%
2024
$14.1M
$11.8M
$4.4M
-4%
+108%
2023
$12.2M
$10.2M
$4.3M
-5%
+52%
2022
$11.3M
$6.6M
$3.9M
-5%
-3%
2021
$10.1M
$13.3M
$3.5M
+17%
+35%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $22.2M sold by insiders over 180 days, 482 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $14.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.7B
four quarters, 2025-10-01 to 2026-09-30
Revenue, TTM VRSN
FY Dec 2025
$1.7B
FY Dec 2024
$1.6B
FY Dec 2023
$1.5B
FY Dec 2022
$1.4B
FY Dec 2021
$1.3B
Sep 2026
$443.0M
Jun 2026
$434.6M
Mar 2026
$428.9M
Dec 2025
$425.3M
Sep 2025
$419.1M
Jun 2025
$409.9M
Mar 2025
$402.3M
Dec 2024
$395.4M
At each fiscal year end
Single quarter
Net margin, TTM
+49.1%
net income over revenue, 2025-10-01 to 2026-09-30
Net margin, TTM VRSN
FY Dec 2025
+49.8%
FY Dec 2024
+50.4%
FY Dec 2023
+54.8%
FY Dec 2022
+47.3%
FY Dec 2021
+59.1%
Sep 2026
+48.0%
Jun 2026
+49.8%
Mar 2026
+50.0%
Dec 2025
+48.5%
Sep 2025
+50.8%
Jun 2025
+50.6%
Mar 2025
+49.5%
Dec 2024
+48.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.0B
operating cash flow minus capex, 2025-10-01 to 2026-09-30
Free cash flow, TTM VRSN
FY Dec 2025
$1.1B
FY Dec 2024
$874.5M
FY Dec 2023
$808.0M
FY Dec 2022
$803.7M
FY Dec 2021
$754.2M
Sep 2026
$260.7M
Jun 2026
$212.8M
Mar 2026
$265.2M
Dec 2025
$285.1M
Sep 2025
$303.0M
Jun 2025
$194.7M
Mar 2025
$285.5M
Dec 2024
$222.0M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity VRSN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt VRSN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity VRSN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+63.3%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on assets VRSN
FY Dec 2025
+60.4%
FY Dec 2024
+49.8%
FY Dec 2023
+47.0%
FY Dec 2022
+36.3%
FY Dec 2021
+41.8%
Sep 2026
+63.3%
Jun 2026
+52.9%
Mar 2026
+61.3%
Dec 2025
+60.4%
Sep 2025
+56.6%
Jun 2025
+54.9%
Mar 2025
+49.8%
Dec 2024
+49.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital VRSN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
capital employed is zero or negative
Return on capital employed VRSN
FY Dec 2025
n/a
FY Dec 2024
+485.5%
FY Dec 2023
+170.0%
FY Dec 2022
+123.6%
FY Dec 2021
+102.7%
Sep 2026
n/a
Jun 2026
+4,466%
Mar 2026
+2,216%
Dec 2025
n/a
Sep 2025
+6,790%
Jun 2025
+469.7%
Mar 2025
+317.2%
Dec 2024
+485.5%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing VRSN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value VRSN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.8%
TTM free cash flow over market value at close 2026-10-27
FCF yield VRSN
FY Dec 2025
+4.7%
FY Dec 2024
+4.4%
FY Dec 2023
+3.8%
FY Dec 2022
+3.7%
FY Dec 2021
+2.7%
Sep 2026
+4.0%
Jun 2026
+4.7%
Mar 2026
+4.6%
Dec 2025
+4.7%
Sep 2025
+3.8%
Jun 2025
+3.5%
Mar 2025
+3.8%
Dec 2024
+4.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing VRSN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
VRSN ranks highest on institutional and government (63rd percentile) and risk and compliance (52nd), and lowest on growth (43rd), among Software & IT peers.
Growth
43
Inputs
Revenue growth, YoY+6.4% · 43 pct, sector of 480
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
46
Inputs
Net Form 4 buying (codes P and S), 180d-$12.9M · 23 pct, sector of 284
Insider buyers, 180d1 · 69 pct, sector of 290
Institutional and government
63
Inputs
Funds adding, latest quarter482 · 92 pct, sector of 415
Congress net buyers, 365d0 · 39 pct, sector of 72
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$520K · 58 pct, sector of 85
Risk and compliance
52
Inputs
Short interest, % of float+2.6% · 65 pct, sector of 528
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+13.4% · 39 pct, sector of 316
3 not measured: Profitability, Financial health, US patents
Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; no debt line filed
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
VRSN filings, in plain words
Are Verisign insiders buying or selling VRSN?
In the 180 days to 2026-10-28, Verisign insiders were net sellers, a net $22.2M: $10.6K of purchases and $22.2M of sales reported on Form 4, by 1 buyer and 4 sellers.
Have members of Congress traded VRSN?
Yes. In the year to 2026-10-28, 1 House member disclosed buying VRSN and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-03-13.
Are there planned insider sales of VRSN?
Yes. 8 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $14.4M of stock; the latest, by DANNY MCPHERSON, was filed 2026-10-26.
Read the full summary
In the 180 days to 2026-10-28, Verisign insiders were net sellers of VRSN, a net $22.2M across purchases and sales reported on Form 4 by 1 buyer and 4 sellers. Sales outweighed purchases more than tenfold by value. 41% of the 115 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 1 member of Congress disclosed buying VRSN and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-03-13. Insiders filed 8 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $14.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.